Recombinant Newcastle disease virus (NDV/Anh-IL-2) expressing human IL-2 as a potential candidate for suppresses growth of hepatoma therapy
/in Hepatocellular Carcinoma, International Publications, Newcastle Disease Virus /von 2016-04-27 / J. Pharmacol. Sci. 2016 Sep;132(1):24-30Tumor-derived exosomes elicit tumor suppression in murine hepatocellular carcinoma models and humans in vitro
/in Exosome, Hepatocellular Carcinoma, International Publications /von 2016-04-15 / Hepatology 2016 08;64(2):456-72Antigen-specific T cell response from dendritic cell vaccination using side population cell-associated antigens targets hepatocellular carcinoma
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2016-03-07 / Tumour Biol. 2016 Aug;37(8):11267-78Current status and perspectives of immune-based therapies for hepatocellular carcinoma
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2016-01-07 / World J. Gastroenterol. 2016 Jan;22(1):253-61A phase I/IIa study of adjuvant immunotherapy with tumour antigen-pulsed dendritic cells in patients with hepatocellular carcinoma
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2015-12-10 / Br. J. Cancer 2015 Dec;113(12):1666-76Clinical research on dendritic cell vaccines to prevent postoperative recurrence and metastasis of liver cancer
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2015-12-08 / Genet. Mol. Res. 2015 Dec;14(4):16222-32Immunotherapy in hepatocellular carcinoma: Primed to make a difference?
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2015-11-05 / Cancer 2016 Feb;122(3):367-77Immunotherapy for hepatocellular carcinoma
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2015-10-01 / Drug Discov Ther 2015 Oct;9(5):363-71Recombinant Newcastle Disease Virus Encoding IL-12 and/or IL-2 as Potential Candidate for Hepatoma Carcinoma Therapy
/in Hepatocellular Carcinoma, International Publications, Newcastle Disease Virus, Pancreatic Cancer /von 2015-08-24 / Technol. Cancer Res. Treat. 2016 10;15(5):NP83-94
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- From Localized Mild Hyperthermia to Improved Tumor Oxygenation: Physiological Mechanisms Critically Involved in Oncologic Thermo-Radio-Immunotherapy
- Individualized Multimodal Immunotherapy for Adults with IDH1 Wild-Type GBM: A Single Institute Experience
- Immunotherapy in breast cancer: an overview of current strategies and perspectives